Provided by Tiger Trade Technology Pte. Ltd.

SIHUAN PHARM

1.690
+0.0503.05%
Volume:16.69M
Turnover:28.12M
Market Cap:15.46B
PE:-72.28
High:1.710
Open:1.640
Low:1.630
Close:1.640
52wk High:1.920
52wk Low:0.526
Shares:9.15B
HK Float Shares:9.15B
Volume Ratio:0.33
T/O Rate:0.18%
Dividend:0.01
Dividend Rate:0.66%
EPS(LYR):-0.023
ROE:-6.73%
ROA:-1.02%
PB:3.11
PE(LYR):-72.28
PS:6.51

Loading ...

Sihuan Pharmaceutical (0460) Announces Xuanzhu Biopharm (2575) Inclusion in Hang Seng Composite Index

Bulletin Express
·
Yesterday

**Xuanzhu Biopharmaceutical Joins Hang Seng Composite Index**Xuanzhu Biopharmaceutical Co., Ltd. said it will be included as a constituent stock of the Hang Seng Composite Index following Hang Seng Indexes’ quarterly review, with the change taking effect on March 9, 2026

Reuters
·
Yesterday

A Look At Sihuan Pharmaceutical Holdings Group (SEHK:460) Valuation After New Earnings Guidance And Segment Growth

Simply Wall St.
·
Feb 19

Sihuan Pharmaceutical (0460) Issues Positive Profit Alert with Strong Growth in Medical Aesthetics and Innovative Drug Segments

Bulletin Express
·
Feb 10

BRIEF-Sihuan Pharma Sees Net Profit Of Not Less Than RMB150 Million For Year

Reuters
·
Feb 10

Sihuan Pharmaceutical Issues Positive Profit Alert, Anticipates Revenue Exceeding RMB 25 Billion for Fiscal Year 2025

Stock News
·
Feb 10

Sihuan Pharma Sees Net Profit of Not Less Than RMB150 Mln for Year

THOMSON REUTERS
·
Feb 10

Sihuan Pharma - Expects Revenue of at Least RMB2,500 Mln in FY

THOMSON REUTERS
·
Feb 10

Sihuan Pharmaceutical Expects Significant Profit Growth for 2025

Reuters
·
Feb 10

Sealand Securities Starts Sihuan Pharmaceutical Holdings Group at Buy

MT Newswires Live
·
Feb 09

Sihuan Pharmaceutical (00460) Announces January 2026 Monthly Return

Bulletin Express
·
Feb 02

Zhytong Hong Kong Stock Analysis | UK Prime Minister's China Visit Boosts Market Sentiment, Price Hike Concepts Strengthen Collectively

Stock News
·
Jan 27

SIHUAN PHARM (00460) Surges Over 9% Again as Institutions Favor Accelerated Dual Growth from Aesthetic and Innovation Drugs

Stock News
·
Jan 27

ZhTong Hong Kong Market Analysis | Strait of Hormuz Sparks Market Jitters, Asset Classes Continue to Draw Interest

Stock News
·
Jan 26

A Look At Sihuan Pharmaceutical (SEHK:460) Valuation After New Polylactic Acid Filler Approvals

Simply Wall St.
·
Jan 24

Hong Kong Stock Movement | SIHUAN PHARM (00460) Rises Nearly 4%, Recent Approval of New "Youthful Needle" Specifications Further Enhances Regenerative Aesthetic Product Market Layout

Stock News
·
Jan 23

Why Investors Shouldn't Be Surprised By Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) P/S

Simply Wall St.
·
Jan 21

Sihuan Pharmaceutical (00460) Gains NMPA Approval for Additional Specifications of Its "Youth Needle" Product

Stock News
·
Jan 16

BRIEF-Sihuan Pharma Says Six New Polylactic Acid Facial Filler Specifications Approved By China's NMPA

Reuters
·
Jan 16

Sihuan Pharma - Six New Polylactic Acid Facial Filler Specifications Approved by Nmpa

THOMSON REUTERS
·
Jan 16